Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argipressin for Blood Loss During Hepatic Resection
NCT05293041Phase 4Completed
- Start
- Mar 2022
- Primary completion
- Dec 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vasopressin in hemorrhage, Systemic Inflammatory Response Syndrome (SIRS). Started Mar 2022; status: completed.
02
Drugs
vasopressin
03
Conditions
hemorrhageSystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT05293041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05293041.